Cortellis Generics Intelligence
The solution helps track opportunities, competition, products, statuses, and data for the generics and biosimilars market.
Data for generics, biosimilars, market entry, and product strategy.
Timing, competitors, patents, regulation, and market signals matter for generics and biosimilars; without the full picture, it is easy to set the wrong priorities.
How this resource supports your organization
Clever Consult demonstrates the solution in the context of the client’s needs, then helps set up access, training and communications, and interpret the results for leadership.
Timing, competitors, patents, regulation, and market signals matter for generics and biosimilars; without the full picture, it is easy to set the wrong priorities.
department leadership, libraries, research offices, and specialist users
Request trial access / a demo
Diagnostic signals
Compare these needs with your organization’s priorities. A consultation helps establish whether the solution is right for you.
there is a pharma/R&D task
competitor, trial, or regulatory monitoring is needed
decisions require curated intelligence rather than ad hoc searching
What changes after implementation
a more accurate picture of R&D and the market
support for pipeline, BD, and strategic decisions
reduced reliance on manual monitoring
Use cases
Value indicators
How Clever Consult launches the solution
How to explain value internally
We already have some of these resources
Then the priority is to assess how well tasks are covered rather than whether access exists: who uses the resource, which scenarios it supports, where gaps remain, and how this relates to KPIs.
It is difficult to justify the budget
We build the case using data, usage, a needs assessment, and implementation scenarios for specific departments.